PillRx only · Injection, Powder, Lyophilized, For Solution · Intravenous
Levothyroxine Sodium Anhydrous
Levothyroxine Sodium Anhydrous
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
286
Rx · 2026 Q1
1.3K
Units dispensed
+4%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 6 | SUPPLYING |
| Endo USA, Inc. | unknown | 3 | SUPPLYING |
| ONESOURCE SPECIALTY PHARMA LIMITED | unknown | 3 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 3 | SUPPLYING |
| MAIA Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Fosun Pharma USA Inc | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.